PACKAGE LEAFLET: INFORMATION FOR THE USER. Tacrolimus 0.1% Ointment Tacrolimus

Similar documents
Package leaflet: Information for the user

Package leaflet: Information for the patient. IsotrexIN Gel erythromycin 2% and isotretinoin 0.05%

Atopic dermatitis/ eczema (a condition that makes skin red and itchy):

Package leaflet: Information for the user. Zoviduo 50 mg/g and 10 mg/g cream. Aciclovir and Hydrocortisone

Package leaflet: Information for the patient. Xemacort 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Package leaflet: Information for the patient. Ezetimibe 10 mg tablets ezetimibe

1.3.1 PACKAGE LEAFLET: INFORMATION FOR THE USER

Package leaflet: Information for the patient UNITED KINGDOM Feldene 5mg/g Gel piroxicam

Package leaflet: Information for the patient. Loratadine 10 mg Tablets (loratadine)

Cutivate 0.05% w/w Cream fluticasone propionate

Package leaflet: Information for the user. Fluticrem 0.05% cream Fluticasone propionate

If you have any questions about how Letrozole Tablets works or why this medicine has been prescribed for you, ask your doctor.

Package leaflet: Information for the patient

FASTUM 2.5% gel PACKAGE LEAFLET: INFORMATION FOR THE USER. What is in this leaflet? 1. WHAT FASTUM GEL IS AND WHAT IT IS USED FOR

Package leaflet: Information for the patient. Mometasone furoate 0.1%w/w Ointment (mometasone furoate)

Package leaflet: Information for the user Oftaquix 5 mg/ml eye drops, solution. Levofloxacin

PACKAGE LEAFLET: INFORMATION FOR THE USER

Read all of this leaflet carefully before you start using this medicine because it contains important information for you.

PACKAGE LEAFLET: INFORMATION FOR THE USER

Tiorfan Hidrasec Tiorfix Tiorfast 100 mg PACKAGE LEAFLET

Patient Leaflet : Information for the user Locoid Cream 0.1% w/w Hydrocortisone butyrate

Package leaflet: Information for the patient. IKERVIS 1 mg/ml, eye drops, emulsion ciclosporin

Hydrocortisyl Skin Cream 1% Hydrocortisone

PACKAGE LEAFLET: INFORMATION FOR THE USER. Lidokain Isdin 40 mg/g cream. Lidocaine

Package leaflet: Information for the user. <product name> 3 mg/ml eye drops, solution. Ofloxacin

Package leaflet: Information for the user. Relestat, 0.5 mg/ml, eye drops, solution Epinastine hydrochloride

1. What Betahistine dihydrochloride tablets is and what it is used for

Package Leaflet: Information for the user. LUMIGAN 0.3 mg/ml, eye drops, solution, in single-dose container Bimatoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER ACULAR 0.5% w/v EYE DROPS, SOLUTION (Ketorolac trometamol)

Package leaflet: Information for the user. Monovo 1 mg/g cutaneous emulsion. mometasone furoate

Package leaflet: Information for the user. Exembol 1 mg/ml solution for infusion. argatroban monohydrate

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. ILAXTEN 20 MG TABLETS bilastine

PACKAGE LEAFLET: INFORMATION FOR THE USER. Anastrozole 1 mg film-coated tablets

Package leaflet: Information for the user. Norditropin SimpleXx 5 mg/1.5 ml solution for injection in cartridge somatropin

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Monovo 1 mg/g ointment. Mometasone furoate

Package leaflet: Information for the user

Package leaflet: Information for the User Clarityn 10 mg tablets Loratadine

Package leaflet: Information for the user

Package leaflet: Information for the User Clarityn 1 mg/ml syrup Loratadine

PACKAGE LEAFLET 1 April 2017

Package Leaflet: Information for the user Laxido Paediatric Plain 6.9 g, powder for oral solution

Package leaflet: Information for the patient. Verkazia 1 mg/ml eye drops emulsion ciclosporin

Patient Information Leaflet

Package leaflet: Information for the user. Levonorgestrel 1.5 mg Tablet. levonorgestrel

Package leaflet: Information for the patient

Package leaflet: Information for the patient. Olumiant 2 mg film-coated tablets Olumiant 4 mg film-coated tablets Baricitinib

Package leaflet: Information for the user. Bupivacaine 0.25% w/v, 0.5% w/v solution for injection Bupivacaine Hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE USER Clotrimazole Cream 1%

Elidel Cream Pimecrolimus 1 % w/w Consumer Medicine Information

PACKAGE LEAFLET: INFORMATION FOR THE USER Pulmicort Turbohaler budesonide. 1. What Pulmicort Turbohaler is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. GRAZAX 75,000 SQ-T oral lyophilisate

PRED FORTE 1% w/v Eye Drops, Suspension Prednisolone acetate

Package leaflet: information for the user

Package leaflet: Information for the patient. Histaclar 10 mg Film-coated Tablets loratadine

Betnovate RD (ready diluted) 0.025% w/w Cream betamethasone (as valerate)

Package leaflet: Information for the patient. Bumetanide 1 mg and 5 mg Tablets (bumetanide)

Ventolin Accuhaler 200 micrograms salbutamol sulfate

Package leaflet: Information for the user. Compound Macrogol Oral Powder Sugar Free

Package leaflet: Information for the patient. Calcium Folinate 15 mg Tablets calcium folinate

Package leaflet: Information for the patient. / / 30 mg/5 ml syrup. Ambroxol hydrochloride

PATIENT INFORMATION LEAFLET. Urea 10% w/w Cream

Package leaflet: Information for the user. Ebateva 20 mg Orodispersible Tablets. Ebastine

1. What Miacalcic is and what it is used for

PACKAGE LEAFLET: INFORMATION FOR THE USER. SALAGEN 5 mg film-coated tablets. Pilocarpine hydrochloride

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Actikerall 5 mg/g mg/g Cutaneous Solution. Fluorouracil + Salicylic acid

Package leaflet: Information for the user. Dalmevin 50 mg tablets Vildagliptin

Package leaflet: Information for the user

Package leaflet: Information for the user

Package leaflet: Information for the user

Package leaflet: Information for the patient

1g cream or ointment contains 1 mg methylprednisolone aceponate.

Package leaflet: Information for the user. NEVANAC 1 mg/ml eye drops, suspension Nepafenac

Proctosedyl Ointment Hydrocortisone/Cinchocaine hydrochloride/framycetin sulphate/aesculin

2 What you need to know before you use Beconase. Package Leaflet: Information for the user

PATIENT INFORMATION LEAFLET. Naseptin Nasal Cream chlorhexidine dihydrochloride and neomycin sulfate

Package leaflet: information for the user. OZURDEX 700 micrograms intravitreal implant in applicator dexamethasone

Motens 2 mg and 4 mg Tablets lacidipine

Package leaflet: Information for the user. Famvir 125, 250 and 500 mg film-coated tablets famciclovir

PACKAGE LEAFLET: INFORMATION FOR THE PATIENT. Estracyt Capsules Estramustine phosphate 140mg (as estramustine sodium phosphate)

Package leaflet: Information for the user. Colecalciferol 3000 IU/ml Oral Solution (colecalciferol)

PACKAGE LEAFLET: INFORMATION FOR THE USER ToboDexin 3 mg/g+1 mg/g eye ointment Tobramycin + Dexamethasone

HERNOVIR 200 mg tablets

Package leaflet: Information for the user. Ursodeoxycholic Acid Tablets 150mg (Ursodeoxycholic acid)

Package leaflet: Information for the patient. Brimonidine Biogaran 2 mg/ml eye drops, solution. brimonidine tartrate

Some general information on hepatitis A infection is given at the end of this leaflet.

PACKAGE LEAFLET: INFORMATION FOR THE USER Nicorandil 10 mg Tablets Nicorandil 20 mg Tablets nicorandil

Package leaflet: Information for the user. CLARELUX 500 microgram/g cutaneous foam in pressurised container (Clobetasol propionate)

Package leaflet: Information for the patient. Eczibet 20 mg/g + 1 mg/g cream (fusidic acid and betamethasone)

Zatamil Mometasone furoate 0.1% w/w

PACKAGE LEAFLET: INFORMATION FOR THE USER AMITIZA 24 MICROGRAM SOFT CAPSULES. Lubiprostone

Package Leaflet: Information for the Patient. FOSRENOL 750 mg chewable tablets. FOSRENOL 1000 mg chewable tablets. lanthanum

RABEPRAZOL 10mg and 20mg Gastro-resistant Tablets

Package leaflet: Information for the user. Latanoprost Pfizer 50 micrograms/ml Eye drops, solution Latanoprost

PACKAGE LEAFLET: INFORMATION FOR THE USER

Package Leaflet: Information for the User Daraprim 25 mg tablets pyrimethamine

Package Leaflet: Information for the user. NEVANAC 3 mg/ml eye drops, suspension nepafenac

Easyhaler Beclometasone 200 micrograms/dose inhalation powder

Transcription:

PACKAGE LEAFLET: INFORMATION FOR THE USER Tacrolimus 0.1% Ointment Tacrolimus Read all of this leaflet carefully before you start using this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Tacrolimus ointment is and what it is used for 2. What you need to know before you use Tacrolimus ointment 3. How to use Tacrolimus ointment 4. Possible side effects 5. How to store Tacrolimus ointment 6. Contents of the pack and other information 1. What Tacrolimus ointment is and what it is used for The active substance of Tacrolimus ointment, tacrolimus monohydrate, is an immunomodulating agent. Tacrolimus 0.1% ointment is used to treat moderate to severe atopic dermatitis (eczema) in adults who are not adequately responsive to or are intolerant of conventional therapies such as topical corticosteroids. Once moderate to severe atopic dermatitis is cleared or almost cleared after up to 6 weeks treatment of a flare, and if you are experiencing frequent flares (i.e. 4 or more per year), it may be possible to prevent flares coming back or prolong the time you are free from flares by using Tacrolimus 0.1% ointment twice weekly. In atopic dermatitis, an over-reaction of the skin s immune system causes skin inflammation (itchiness, redness, dryness). Tacrolimus ointment alters the abnormal immune response and relieves the skin inflammation and the itch. 2. What you need to know before you use Tacrolimus ointment Do not use Tacrolimus ointment - If you are allergic (hypersensitive) to tacrolimus or any of the other ingredients of Tacrolimus ointment (listed in section 6) or to macrolide antibiotics (e.g. azithromycin, clarithromycin, erythromycin). Warnings and precautions Talk to your doctor if you: have liver failure

have any skin malignancies (tumours) or if you have a weakened immune system (immunocompromised) whatever the cause. have an inherited skin barrier disease such as Netherton s syndrome, lamellar ichthyosis (extensive scaling of the skin due to a thickening of the outer layer of the skin), or if you suffer from generalised erythroderma (inflammatory reddening and scaling of the entire skin). have a cutaneous Graft Versus Host Disease (an immune reaction of the skin which is a common complication in patients who have undergone a bone marrow transplant). have swollen lymph nodes at initiation of treatment. If your lymph nodes become swollen during treatment withtacrolimus ointment, consult your doctor have infected lesions. Do not apply the ointment to infected lesions. notice any change to the appearance of your skin, please inform your physician. The safety of using tacrolimus ointment for a long time is not known. A very small number of people who have used tacrolimus ointment have had malignancies (for example, skin or lymphoma). However, a link to tacrolimus ointment treatment has not been shown. Avoid exposing the skin to long periods of sunlight or artificial sunlight such as tanning beds. If you spend time outdoors after applying Tacrolimus ointment, use a sunscreen and wear loose fitting clothing that protects the skin from the sun. In addition, ask your doctor for advice on other appropriate sun protection methods. If you are prescribed light therapy, inform your doctor that you are using Tacrolimus ointment as it is not recommended to use Tacrolimus ointment and light therapy at the same time. If your doctor tells you to use Tacrolimus ointment twice weekly to keep your atopic dermatitis cleared, your condition should be reviewed by your doctor at least every 12 months, even if it remains under control. In children, maintenance treatment should be suspended after 12 months, to assess whether the need for continued treatment still exists. Patients should be advised not to bathe, shower or swim immediately after applying the ointment; water may wash off the medicine. Children Tacrolimus 0.1 % ointment is not approved for children younger than 16 years of age. Therefore it should not be used in this age group. Please consult your doctor. The effect of treatment with Tacrolimus ointment on the developing immune system in children, especially the young, has not been established. Other medicines, cosmetics and Tacrolimus ointment Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. You may use moisturising creams and lotions during treatment with Tacrolimus ointment but these products should not be used within two hours of applying Tacrolimus ointment. The use of tacrolimus at the same time as other preparations to be used on the skin or while taking oral corticosteroids (e.g. cortisone) or medicines which affect the immune system has not been studied. Tacrolimus ointment with alcohol While using Tacrolimus ointment, drinking alcohol may cause the skin or face to become flushed or red and feel hot. Pregnancy and breast-feeding Do not use Tacrolimus ointment if you are pregnant or breast-feeding. Ask your doctor or pharmacist for advice before taking any medicine. 3. How to use Tacrolimus ointment

Always use Tacrolimus ointment exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure. Apply Tacrolimus ointment as a thin layer to affected areas of your skin. Tacrolimus ointment may be used on most parts of the body, including the face and neck and in the creases of your elbows and knees. Avoid using the ointment inside your nose or mouth or in your eyes. If the ointment gets on any of these areas, it should be thoroughly wiped off and/or rinsed off with water. Do not cover the skin being treated with bandages, wraps or other wound dressing. Wash your hands after applying Tacrolimus ointment unless your hands are also being treated. Before applying Tacrolimus ointment after a bath or shower, be sure your skin is completely dry. Do not bathe, shower, or swim immediately after applying the ointment. Water may wash off the medicine. Adults (16 years of age and older) Two strengths of tacrolimus ointment (tacrolimus 0.03% ointment and tacrolimus 0.1% ointment) are available for adult patients (16 years of age and older). Your doctor will decide which strength is best for you. Usually, treatment is started with Tacrolimus 0.1% ointment twice a day, once in the morning and once in the evening, until the eczema has cleared. Depending on the response of your eczema your doctor will decide if the frequency of application can be reduced or the lower strength, tacrolimus 0.03% ointment, can be used. Treat each affected region of your skin until the eczema has gone away. Improvement is usually seen within one week. If you do not see any improvement after two weeks, see your doctor about other possible treatments. You may be told by your doctor to use Tacrolimus 0.1% ointment twice weekly once your atopic dermatitis has cleared or almost cleared. Tacrolimus 0.1 % ointment should be applied once a day twice weekly (e.g. Monday and Thursday) to areas of your body commonly affected by atopic dermatitis. There should be 2 3 days without Tacrolimus ointment treatment between applications. If symptoms reappear you should use Tacrolimus ointment twice daily as outlined above and arrange to see your doctor to review your treatment. If you accidentally swallow some ointment If you accidentally swallow the ointment, consult your doctor or pharmacist as soon as possible. Do not try to induce vomiting. If you forget to use Tacrolimus ointment If you forget to apply the ointment at the scheduled time, do it as soon as you remember and then continue as before. If you have any further questions on the use of this product, ask your doctor or pharmacist. 4. Possible side effects Like all medicines, Tacrolimus ointment can cause side effects, although not everybody gets them. Very common (may affect more than 1 in 10 people): burning sensation and itching These symptoms are usually mild to moderate and generally go away within one week of using Tacrolimus ointment.

Common (may affect up to 1 in 10 people): redness feeling of warmth pain increased skin sensitivity (especially to hot and cold) skin tingling and irritation rash local skin infection regardless of specific cause including but not limited to: inflamed or infected hair follicles, cold sores, generalised herpes simplex infections facial flushing or skin irritation after drinking alcohol is also common application site hypersensitivity Uncommon (may affect fewer than 1 in 100 people): acne Following twice-weekly treatment application site infections have been reported in adults. Rosacea (facial redness), rosacea-like dermatitis, lentigo (presence of flat brown spots on the skin), oedema at the application site and herpes eye infections have been reported during post-marketing experience. Since commercial availability a very small number of people who have used tacrolimus ointment have had malignancies (for example lymphoma, including skin lymphoma, and other skin tumours). However, a link to tacrolimus ointment treatment has not been confirmed or refuted on the available evidence so far. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. By reporting side effects you can help provide more information on the safety of this medicine. For UK- You can also report side effects directly via Yellow Card Scheme,Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. 5. How to store Tacrolimus ointment Keep out of the sight and reach of children. Do not use Tacrolimus ointment after the expiry date which is stated on the tube and carton after EXP. The expiry date refers to the last day of that month. Do not store above 25ºC. Discard open tubes 90 days after opening, even if they are not empty. They should not be kept for future use. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment. 6. Contents of the pack and other information What Tacrolimus ointment contains - The active substance is tacrolimus monohydrate.

One gram of Tacrolimus 0.1% ointment contains 1.0 mg tacrolimus (as tacrolimus monohydrate). - The other ingredients are paraffin, white soft; paraffin liquid; propylene carbonate; beeswax, white; paraffin hard. What Tacrolimus ointment looks like and contents of the pack Tacrolimus ointment is a white to slightly yellowish ointment. It is supplied in tubes containing 10, 30 or 60 grams of ointment. Not all pack sizes may be marketed. Marketing Authorisation Holder and Manufacturer Marketing Authorisation Holder Accord Healthcare Limited Sage House, 319, Pinner Road North Harrow, Middlesex, HA1 4HF United Kingdom Manufacturer: Accord Healthcare Limited Sage House, 319 Pinner Road North Harrow, Middlesex, HA1 4HF United Kingdom LABORATORI FUNDACIÓ DAU Pol. Ind. Consorci Zona Franca, c/ C, 12-14 Barcelona 08040 Spain Wessling Hungary Kft. Fòti ùt 56., Budapest 1047 Hungary This medicinal product is authorised in the Member States of the EEA under the following names: Name of the Member State Name of the medicinal product Austria Tacrolimus Accord 0,1% Salbe Cyprus Tacrolimus Accord Germany Tacrolimus Accord 1mg/g Salbe Denmark Tacrolimus Accord Finland Tacrolimus Accord 0,1% voide Ireland Tacrolimus 0.1% ointment Malta Tacrolimus 0.1% ointment Netherland Tacrolimus Accord 1mg/g zalf Norway Takrolimus Accord Sweden Takrolimus Accord 0,1% salva United Kingdom Tacrolimus Accord 0.1% ointment This leaflet was last revised in 11/2017.